Scientists Reversed Aging in Monkeys. Humans Could Be Next
Scientists demonstrated that senescence resistant mesenchymal progenitor cells (SRCs), engineered with the longevity gene FOXO3, can not only halt aging but partially reverse it in aged macaques. 👀
Intravenous SRC treatment improved cognition, bone strength, and reproductive health without adverse effects.
Mechanistically, SRC derived exosomes reduced cellular senescence markers (p21CIP1, γH2AX), inflammation (IL-1β, TNF-α, IL-6), and oxidative stress, while enhancing heterochromatin stability (H3K9me3, lamin B1) and immune function.
This suppressed the cGAS-STING inflammatory pathway and promoted systemic rejuvenation.
This research suggests aging is not just inevitable decline but a treatable condition.
SRCs outperformed conventional stem cells, reversing multiple hallmarks of aging across organ systems.
The findings offer a proof of concept for human anti aging therapies.